Decolonization
Decolonization is a pharmaceutical drug with 5 clinical trials. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
60.0%
3 of 5 finished
40.0%
2 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers
Decolonization of Patients Carrying S. Aureus Before Cardiac Surgery: Study of the Risk Factors Associated With Failure
Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities
Effect of Topical and Systemic Decolonization of Staphylococcus Aureus (SA) in Pediatric Cystic Fibrosis (CF) Patients
Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study
Clinical Trials (5)
Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers
Decolonization of Patients Carrying S. Aureus Before Cardiac Surgery: Study of the Risk Factors Associated With Failure
Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities
Effect of Topical and Systemic Decolonization of Staphylococcus Aureus (SA) in Pediatric Cystic Fibrosis (CF) Patients
Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5